会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Process for the Preparation of a Diastereomerically Enriched Compound
    • 制备非对映异构体的化合物的方法
    • US20080167500A1
    • 2008-07-10
    • US11632699
    • 2005-07-20
    • Quirinus Bernardus BroxtermanBen De LangeHenrius Leonardus Marie ElsenbergMatthias Weber
    • Quirinus Bernardus BroxtermanBen De LangeHenrius Leonardus Marie ElsenbergMatthias Weber
    • C07C211/01
    • C07C209/28C07C2601/02C07C211/17C07C211/27C07C211/29
    • The present invention relates to a process for the preparation of a diastereomerically enriched compound, wherein a first compound according to formula (I), is contacted with a second compound according to formula (II), to form a third compound according to formula (III), whereby the compound according to formula (III) is subsequently reduced and thereby converted into a compound according to formula (IV), in which formulas: R1=a cycloalkyl group whereby R1 # R2, R2=a substituted or unsubstituted: (cyclo)alkyl group, (cyclo)alkenyl group, aryl group, cyclic or acyclic heteroalkyl group or heteroaryl group, R3=an alkyl group, R4=a substituted or unsubstituted: phenyl- or naphthyl-group, *=a chiral center. The invention furthermore relates to a diastereomerically enriched compound according to formula (IV) and its use in the preparation of pharmaceutical and agrochemically active compounds. The invention further relates to a process for the preparation of enantiomerically enriched compounds of formula (V), through hydrogenolysis of diastereomerically enriched compounds of formula (IV), wherein R1 and R2 have the meanings given above.
    • 本发明涉及一种制备非对映体富集的化合物的方法,其中根据式(I)的第一化合物与式(II)的第二化合物接触,以形成式(III)的第三化合物 ),由此将式(III)化合物随后还原,从而转化成式(Ⅳ)化合物,其中R 1 =环烷基,其中R 1 (环)烷基,(环)烯基,芳基,环状或无环杂烷基的取代或未取代的 或杂芳基,R 3 =烷基,R 4 =取代或未取代的:苯基或萘基,* =手性中心。 本发明还涉及根据式(IV)的非对映异构体富集的化合物及其在制备药物和农业化学活性化合物中的用途。 本发明还涉及通过氢解非对映体富集的式(Ⅳ)化合物来制备对映体富集的式(Ⅴ)化合物的方法,其中R 1和R 2, SUB>具有上述含义。
    • 8. 发明授权
    • Process for the preparation of enantiomerically enriched esters and alcohols
    • 用于制备对映体富集的酯和醇的方法
    • US06841691B2
    • 2005-01-11
    • US10296840
    • 2001-05-21
    • Gerardus Karel Maria VerzijlJohannes Gerardus Vries DeQuirinus Bernardus Broxterman
    • Gerardus Karel Maria VerzijlJohannes Gerardus Vries DeQuirinus Bernardus Broxterman
    • C07B53/00C07B55/00C07C29/143C07C33/20C12P41/00C11G3/00
    • C12P41/004
    • Method for the preparation of an enantiomerically enriched ester, in which a mixture of the enantiomers of the corresponding secondary alcohol is subjected, in the presence of an acyl donor, to an enantioselective conversion in the presence of a racemisation catalyst upon which the ester is formed and an acyl donor residue is obtained, and in which the acyl donor residue is irreversibly removed from the phase in which the enantioselective conversion takes place. Preferably the enantioselective conversion is carried out enzymatically and a transfer hydrogenation catalyst is used as racemisation catalyst.The secondary alcohol can be formed in situ from the corresponding ketone, in the presence of a hydrogen donor. It is also possible to use a mixture of the secondary alcohol and the corresponding ketone as substrate.Preferably the acyl donor is chosen so that the acyl donor residue is converted in situ into another compound and/or the acyl donor residue is removed via distillation under reduced pressure.The enantiomerically enriched esters obtained can subsequently be converted into the corresponding enantiomerically enriched alcohols, which are desirable intermediate products in the preparation of liquid crystals, agro chemicals or pharmaceuticals.
    • 制备对映异构体富集的酯的方法,其中将相应的仲醇的对映异构体的混合物在酰基供体的存在下在形成酯的外消旋催化剂存在下进行对映选择性转化 并且获得酰基供体残基,并且其中酰基供体残基从其中进行对映选择性转化的相不可逆地除去。 优选地,对映选择性转化酶进行酶促转移氢化催化剂作为外消旋化催化剂。仲醇可以在氢供体存在下由相应的酮原位形成。 还可以使用仲醇和相应的酮的混合物作为底物。优选地选择酰基供体,使得酰基供体残基原位转化成另一种化合物和/或通过蒸馏除去酰基供体残留物 所得到的对映异构体富集的酯可以随后转化成相应的对映异构体富集的醇,这在制备液晶,农用化学品或药物中是理想的中间产物。
    • 9. 发明授权
    • Process for the preparation of alkynols
    • 制备炔醇的方法
    • US07371901B2
    • 2008-05-13
    • US10575757
    • 2004-10-14
    • Quirinus Bernardus BroxtermanGerardus Karel Maria Verzijl
    • Quirinus Bernardus BroxtermanGerardus Karel Maria Verzijl
    • C07C27/10C07C29/10C07C35/00
    • C12P7/04C07C29/00C07C29/095C12P9/00C12P41/007C07C33/042
    • Process for the preparation of an alkynol with formula HC≡C—CH(OH)—R2(formula 2) wherein R2 represents methyl, halomethyl or ethyl, wherein the corresponding silyl-protected alkynol ester with formula 1 wherein R1 represents H, or an optionally substituted alkyl, an optionally substituted alkenyl or an optionally substituted (hetero)aryl group, R2 is as defined above and A3Si represents a trisubstituted silyl group wherein each A independently represents an optionally substituted alkyl or an optionally substituted (hetero)aryl group, in the presence of water and at least an equivalent amount of amine functionalities is converted into the alkynol with formula 2. Preferably, the amount of water is between 0.5 and 3 equivalents calculated with respect to the amount of silyl-protected alkynol ester with formula (1).
    • 其中R 2代表甲基,卤代甲基或乙基的具有式HC≡C-CH(OH)-R 2(式2)的炔醇的方法,其中 相应的具有式1的甲硅烷基保护的炔醇酯,其中R 1表示H,或任选取代的烷基,任选取代的烯基或任选取代的(杂)芳基,R 2 O >如上所定义,并且A 3 Si表示三取代的甲硅烷基,其中每个A独立地表示任选取代的烷基或任选取代的(杂)芳基,在水存在下和至少相当于 胺官能团的量被转化为具有式2的炔醇。优选地,相对于式(1)的甲硅烷基保护的炔醇酯的量,水的量为0.5-3当量。
    • 10. 发明授权
    • Process for the preparation of enantiomerically enriched compounds
    • 制备富含对映体的化合物的方法
    • US07183443B2
    • 2007-02-27
    • US10510660
    • 2003-04-07
    • Bernardus Henricus Nicolaas DassenBernardus KapteinQuirinus Bernardus Broxterman
    • Bernardus Henricus Nicolaas DassenBernardus KapteinQuirinus Bernardus Broxterman
    • C07C45/44C07C29/48
    • C12P13/02C07B2200/07C07C213/00C07C221/00C12P13/001C07C215/08C07C223/02
    • Process for the preparation of enantiomerically enriched amino aldehydes and amino alcohols, wherein a corresponding enantiomerically enriched amino nitrile is subjected to hydrogenation in the presence of hydrogen, a hydrogenation catalyst, preferably a Pd-catalyst and a mineral acid. For the preparation of an amino aldehyde hydrogen preferably is present at a hydrogen-pressure between 0.1 and 2 MPa, in particular between 0.5 and 1 MPa. The amino aldehyde preferably is isolated in the form of a chemically and configurationally stable derivative. For the preparation of an amino alcohol, preferably at least during part of the hydrogenation hydrogen is present at a hydrogen-pressure between 2 and 10 MPa, in particular between 4 and 6 MPa. In a preferred embodiment the hydrogen-pressure initially is between 0.5 and 2 MPa and subsequently, after most of the nitrile starting material is converted, the hydrogen pressure is increased to a value between 2 and 10 MPa. The enantiomerically enriched nitrile starting material may a.o. be prepared by enzymatic resolution, classical resolution, resolution via preferential crystallization, diastereomeric synthesis, catalytic asymmetric synthesis or dehydratation of amino acid amides.
    • 用于制备对映异构体富集的氨基醛和氨基醇的方法,其中相应的对映异构体富集的氨基腈在氢气,氢化催化剂,优选Pd-催化剂和无机酸的存在下进行氢化。 对于氨基醛的制备,氢优选以0.1至2MPa,特别是0.5至1MPa的氢压存在。 氨基醛优选以化学和结构稳定的衍生物的形式分离。 对于氨基醇的制备,优选至少在部分氢化过程中,氢气的压力为2至10MPa,特别是4至6MPa。 在一个优选的实施方案中,氢气压力最初为0.5-2MPa,随后在大部分腈起始原料转化后,氢气压力增加至2MPa至10MPa。 对映异构体富集的腈起始物质可以是 通过酶解,经典拆分,优化结晶,非对映体合成,催化不对称合成或氨基酸酰胺脱水制备。